Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus

Member of:

  • Neurology


Publication year:
All
61 - 70 out of 256Page size: 10
  1. 2010
  2. Published

    Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

    Ravnborg, M., Sørensen, Per Soelberg, Andersson, M., Celius, E. G., Jongen, P. J., Elovaara, I., Bartholomé, E., Constantinescu, C. S., Beer, K., Garde, E. & Sperling, B., 1 Jul 2010, In: Lancet Neurology. 9, 7, p. 672-80 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

    Polman, C. H., Bertolotto, A., Deisenhammer, F., Giovannoni, G., Hartung, H., Hemmer, B., Killestein, J., McFarland, H. F., Oger, J., Pachner, A. R., Petkau, J., Reder, A. T., Reingold, S. C., Schellekens, H. & Sørensen, Per Soelberg, 1 Jul 2010, In: Lancet Neurology. 9, 7, p. 740-50 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    EFNS guidelines on diagnosis and management of neuromyelitis optica

    Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illes, Z., Montalban, X., Du Pasquier, R. A., Polman, C. H., Sørensen, Per Soelberg & Hemmer, B., 1 Aug 2010, In: European Journal of Neurology. 17, 8, p. 1019-32 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients

    Enevold, Christian, Oturai, A. B., Sørensen, Per Soelberg, Ryder, L. P., Koch-Henriksen, N. & Bendtzen, K., 1 Aug 2010, In: Multiple Sclerosis. 16, 8, p. 942-9 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Demyelination versus remyelination in progressive multiple sclerosis

    Bramow, S., Frischer, J. M., Lassmann, H., Koch-Henriksen, N., Lucchinetti, C. F., Sørensen, Per Soelberg & Laursen, H., 1 Oct 2010, In: Brain. 133, 10, p. 2983-98 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. 2011
  8. Published

    Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655

    Søndergaard, H. B., Sellebjerg, Finn Thorup, Hillert, J., Olsson, T., Kockum, I., Lindén, M., Mero, I., Myhr, K., Celius, E. G., Harbo, H. F., Christensen, J. R., Börnsen, L., Sørensen, Per Soelberg & Oturai, A. B., 2011, In: European Journal of Human Genetics. 19, 10, p. 1100-3 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C. C. A., Patsopoulos, N. A., Moutsianas, L., Dilthey, A., Su, Z., Freeman, C., Hunt, S. E., Edkins, S., Gray, E., Booth, D. R., Potter, S. C., Goris, A., Band, G., Oturai, A. B., Strange, A., Saarela, J., Bellenguez, C. & 31 others, Fontaine, B., Gillman, M., Hemmer, B., Gwilliam, R., Zipp, F., Jayakumar, A., Martin, R., Leslie, S., Hawkins, S., Giannoulatou, E., D'alfonso, S., Blackburn, H., Boneschi, F. M., Liddle, J., Harbo, H. F., Perez, M. L., Spurkland, A., Waller, M. J., Mycko, M. P., Ricketts, M., Comabella, M., Hammond, N., Kockum, I., McCann, O. T., Ban, M., Whittaker, P., Kemppinen, A., Weston, P., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg & International Multiple Sclerosis Genetics Consortium, I. M. S. G. C., 2011, In: Nature. 476, 7359, p. 214-9 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis

    Sellebjerg, Finn Thorup, Hedegaard, C. J., Krakauer, M., Hesse, D., Lund, H., Nielsen, Claus Henrik, Søndergaard, H. B. & Sørensen, Per Soelberg, 2011, In: Multiple Sclerosis.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

    Kappos, L., Bates, D., Edan, G., Eraksoy, M., Garcia-Merino, A., Grigoriadis, N., Hartung, H-P., Havrdová, E., Hillert, J., Hohlfeld, R., Kremenchutzky, M., Lyon-Caen, O., Miller, A., Pozzilli, C., Ravnborg, M., Saida, T., Sindic, C., Vass, K., Clifford, D. B., Hauser, S. & 9 others, Major, E. O., O'Connor, P. W., Weiner, H. L., Clanet, M., Gold, R., Hirsch, H. H., Radü, E., Sørensen, Per Soelberg & King, J., 2011, In: Lancet Neurology. 10, 8, p. 745-58 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Neutralizing antibodies against interferon-β do not predispose antibodies against natalizumab

    Sørensen, Per Soelberg, Koch-Henriksen, N. & Jensen, P. E. H., 2011, In: Neurology. 76, 8, p. 759-60 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...3 4 5 6 7 8 9 10 ...26 Next

ID: 11025